Paperpal Prime Logo

Frontiers in Immunology : Impact Factor & More

eISSN: 1664-3224pISSN: 1664-3224
JournalOpen Access

Key Metrics

CiteScore
9.8
Eigenfactor
0.1 - 0.5
Impact Factor
5 - 10
Scite Index
0.92 5-Year SI
SJR
Q1Immunology
SNIP
1.78
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Frontiers in Immunology

Frontiers in Immunology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher FRONTIERS MEDIA SA
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2950
Publication Time14
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 14
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Frontiers in Immunology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Frontiers in Immunology

Correction: Transcriptomic profiling of autoimmune hepatitis identifies TRAT1 as an in vitro negative regulator of NK cell effector functions
  • 7 Aug 2026
  • Frontiers in Immunology
A systemic epithelial–immune–neural framework for pediatric atopic dermatitis–allergic rhinitis comorbidity
  • 7 Aug 2026
  • Frontiers in Immunology
Idiopathic granulomatous mastitis with GMENA syndrome: clinical features, glucocorticoid response, and prognosis – a 12-year retrospective cohort study from a single center
  • 5 Aug 2026
  • Frontiers in Immunology
Chicken heterophils as evolutionary models: insights into myeloperoxidase-independent antimicrobial strategies
  • 3 Aug 2026
  • Frontiers in Immunology
TREM2 as a central immunometabolic hub in Alzheimer’s disease: linking microglial states, lipid stress, and disease-stage-specific intervention
  • 31 Jul 2026
  • Frontiers in Immunology
Ferritin heavy chain 1 expression is correlated with plasma cell exhaustion and acts as a prognostic correlative marker in hepatocellular carcinoma
  • 31 Jul 2026
  • Frontiers in Immunology
Correction: Transcriptomic profiling of autoimmune hepatitis identifies TRAT1 as an in vitro negative regulator of NK cell effector functions
  • 7 Aug 2026
  • Frontiers in Immunology
A systemic epithelial–immune–neural framework for pediatric atopic dermatitis–allergic rhinitis comorbidity
  • 7 Aug 2026
  • Frontiers in Immunology
Idiopathic granulomatous mastitis with GMENA syndrome: clinical features, glucocorticoid response, and prognosis – a 12-year retrospective cohort study from a single center
  • 5 Aug 2026
  • Frontiers in Immunology
Chicken heterophils as evolutionary models: insights into myeloperoxidase-independent antimicrobial strategies
  • 3 Aug 2026
  • Frontiers in Immunology
TREM2 as a central immunometabolic hub in Alzheimer’s disease: linking microglial states, lipid stress, and disease-stage-specific intervention
  • 31 Jul 2026
  • Frontiers in Immunology
Ferritin heavy chain 1 expression is correlated with plasma cell exhaustion and acts as a prognostic correlative marker in hepatocellular carcinoma
  • 31 Jul 2026
  • Frontiers in Immunology

FAQs on Frontiers in Immunology